Viewing Study NCT00472433


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-01-08 @ 7:33 AM
Study NCT ID: NCT00472433
Status: TERMINATED
Last Update Posted: 2009-06-22
First Post: 2007-04-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Efficacy and Safety of Alemtuzumab in Auotoimmune Cytopenias
Sponsor: Phramongkutklao College of Medicine and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module